Drug recall · June 1, 2016
LIPO ESCULTURA capsules recall
Why: Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com
- Lots / codes
All lots
- Quantity
- unknown
- Company
- Lipo Escultura Corp., Brooklyn, NY
- Distribution
- Nationwide via Internet sales
- Initiated
- December 3, 2015 · Voluntary: Firm initiated
- Classified
- May 23, 2016
- Reported
- June 1, 2016
- Ended
- April 17, 2017
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.